World's Best Scientists 2026 revealed!
Steven Joniau

Steven Joniau

D-Index & Metrics

Medicine

D-Index
86
Citations
40370
World Ranking
13882
National Ranking
171

Overview

Steven Joniau is affiliated with KU Leuven in Belgium and has contributed extensively to medical research, particularly in the field of oncology with a strong focus on urologic cancers. Their work spans a variety of topics related to prostate, bladder, and renal cell carcinoma treatment and diagnosis.

The scientist's recent publications cover important clinical trials and outcomes in oncology. Notable papers include:

  • "Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials" (2022, Journal of Clinical Oncology)
  • "Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial." (2020, Journal of Clinical Oncology)
  • "Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial" (2020, Journal of Clinical Oncology)
  • "Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial 'NIMBUS'" (2020, European Urology)
  • "Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought" (2020, European Urology)

The key themes apparent across their research include prostate cancer treatment and research, prostate cancer diagnosis and treatment, bladder and urothelial cancer treatments, cancer-related lipid metabolism, urinary and genital oncology studies, renal cell carcinoma treatment, and urologic and reproductive health conditions.

Frequent collaborators in their research include Gaëtan Devos, Hendrik Van Poppel, Gert De Meerleer, Alberto Briganti, and Charlien Berghen, each having numerous coauthored works with Steven Joniau.

Steven Joniau contributes regularly to a range of scholarly journals, with a particular emphasis on the following publication venues:

  • European Urology Open Science
  • European Urology
  • The Journal of Urology
  • European Urology Oncology
  • Cancers

The scientist's academic output predominantly falls within the broad field of Medicine. Subfields of their research include Pulmonary and Respiratory Medicine, Surgery, Radiology, Nuclear Medicine and Imaging, Cancer Research, and Rheumatology, demonstrating a multidisciplinary approach to health sciences and oncologic care.

Best Publications

  • EAU–ESTRO–SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

    Nicolas Mottet;Joaquim Bellmunt;Michel Bolla;Erik Briers

  • EAU guidelines on prostate cancer

    Axel Heidenreich;Gunnar Aus;Michel Bolla;Steven Joniau

  • EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

    Axel Heidenreich;Patrick J. Bastian;Joaquim Bellmunt;Michel Bolla

  • EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

    Axel Heidenreich;Joaquim Bellmunt;Michel Bolla;Steven Joniau

  • EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

    Philip Cornford;Joaquim Bellmunt;Michel Bolla;Erik Briers

  • EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer ☆

    Nicolas Mottet;Joaquim Bellmunt;Michel Bolla;Steven Joniau

  • Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

    Piet Ost;Dries Reynders;Karel Decaestecker;Valérie Fonteyne

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Guidelines on Prostate Cancer

    A. Heidenreich;J. Bellmunt;M. Bolla;S. Joniau

  • The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review

    Nicola Fossati;Peter-Paul M. Willemse;Thomas Van den Broeck;Roderick C.N. van den Bergh

  • Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer

    Johannes V. Swinnen;Tania Roskams;Steven Joniau;Hein Van Poppel

  • What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel

    Paul C. Moldovan;Thomas Van den Broeck;Richard Sylvester;Lorenzo Marconi

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    David V. Conti;Burcu F. Darst;Lilit C. Moss;Edward J. Saunders

  • Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

    Karim Bensalah;Allan J. Pantuck;Nathalie Rioux-Leclercq;Rodolphe Thuret

  • Radiotherapy for renal-cell carcinoma

    Gert De Meerleer;Vincent Khoo;Bernard Escudier;Steven Joniau

  • Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology.

    Jean Pierre Droz;Lodovico Balducci;Michel Bolla;Mark Emberton

  • Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

    Steven Joniau;Laura Van den Bergh;Evelyne Lerut;Christophe M. Deroose

  • Selective activation of the fatty acid synthesis pathway in human prostate cancer.

    Johannes V. Swinnen;Frank Vanderhoydonc;Abdelaziz A. Elgamal;Marianne Eelen

  • Guía de la EAU sobre el cáncer de próstata: Parte II: tratamiento del cáncer de próstata avanzado, recidivante y resistente a la castración

    N. Mottet;Joaquim Bellmunt;M. Bolla;S. Joniau

  • EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer - Guía de la EAU sobre el cáncer de próstata. Parte II: tratamiento del cáncer de próstata avanzado, recidivante y resistente a la castración

    N. Mottet;J. Bellmunt;M. Bolla;S. Joniau

Frequent Co-Authors

Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Bertrand Tombal
Bertrand Tombal Université Catholique de Louvain
Giorgio Gandaglia
Giorgio Gandaglia Vita-Salute San Raffaele University
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Tania Roskams
Tania Roskams KU Leuven

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can expand your career options and meet the growing demand for skilled professionals. For those interested in advanced practice roles, you can consider the shortest dnp programs available online, which allow you to earn a Doctor of Nursing Practice degree more quickly than traditional routes.

If the thought of intensive academic research holds you back, there are accredited online dnp programs without dissertation, letting you focus on clinical practice and leadership skills instead.

For those seeking entry into nursing with a faster timeline, consider accredited lpn programs that can be completed online, launching your career in less than a year.

Already a registered nurse? Fast-track your specialization with bsn to np programs online and become a psychiatric mental health nurse practitioner—an in-demand field with many growth opportunities.

Whether you’re just starting or looking to advance, these flexible online programs make it easier to achieve your healthcare career goals.

Best Scientists Citing Steven Joniau

Trending Scientists